Enforcement Report - Week of March 29, 2023
Enforcement Report - Week of March 8, 2023
Teva Pharma`s Generic Dofetilide Receives Approval in U.S.
Mylan's Generic Budenoside and Formoterol Fumarate Receives Approval in the U.S.
Granules India ’s Generics Dofetilide Receives Approvals In US
Granules India announced that the USFDA has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc. for dofetilide capsules.
MSN`s Generic Dofetilide Receives Approval in US
Riconpharma`s Generic Dofetilide Receives Approval in US
BENGALURU: BioconNSE 0.26 % said it has given exclusive rights to Equillium for developing and commercializing itolizumab in Australia and New Zealand.
Pfizer’s Tikosyn (dofetilide) has been available since 1999 to help treat patients with irregular heartbeats. Now, years after the drug has gone generic, scientists at Georgetown University have found a potential new use for it—treating pulmonary arterial hypertension (PAH).